Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)
Clinical trial NCT03633617 · COMPLETED
Trial details
- NCT number
- NCT03633617
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-24
- Primary completion
- 2021-09-09
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.